BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2847857)

  • 1. [Importance of fluorescent lipid substrates for the study of hereditary lysosomal lipidoses. Application to the diagnosis of Niemann-Pick disease].
    Douste-Blazy L; Levade T; Salvayre R; Gatt S
    Bull Acad Natl Med; 1988 Jun; 172(6):807-13. PubMed ID: 2847857
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and biochemical diagnostics of Niemann-Pick disease.
    Maciejko D; Tylki-Szymańska A
    Klin Padiatr; 1986; 198(2):103-6. PubMed ID: 3009958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific enzymatic diagnosis and ultrastructural analysis of peripheral leukocytes in infantile form of Niemann-Pick sphingomyelinosis.
    László A; Klujber L; Streitmann K; Barb E
    Acta Paediatr Hung; 1990; 30(1):99-105. PubMed ID: 2156543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcellular localization of acid sphingomyelinase and lipid in Niemann-Pick mice.
    Sakiyama T; Akashi K; Akatsuka A; Owada M; Miyawaki S; Kitagawa T
    J Inherit Metab Dis; 1987; 10(3):301-4. PubMed ID: 2828764
    [No Abstract]   [Full Text] [Related]  

  • 5. An animal model of human acid sphingomyelinase deficiency (Niemann-Pick disease) and the study of its enzyme replacement (the Japan Society of Human Genetics award lecture).
    Kitagawa T
    Jinrui Idengaku Zasshi; 1987 Jun; 32(2):55-69. PubMed ID: 2830422
    [No Abstract]   [Full Text] [Related]  

  • 6. Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation.
    Christomanou H
    Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1489-502. PubMed ID: 6256275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingomyelinase defect in Niemann-Pick disease, type C, fibroblasts.
    Besley GT
    FEBS Lett; 1977 Aug; 80(1):71-4. PubMed ID: 19295
    [No Abstract]   [Full Text] [Related]  

  • 8. [Niemann-Pick disease revealed late by miliary tuberculosis: diagnosis by leukocyte determination of sphingomyelinase deficiency].
    Kofman J; Chevalier JP; Brun J
    Nouv Presse Med; 1978 Dec; 7(45):4147. PubMed ID: 218165
    [No Abstract]   [Full Text] [Related]  

  • 9. Sphingomyelinases and Niemann-Pick disease.
    Levade T; Salvayre R; Douste-Blazy L
    J Clin Chem Clin Biochem; 1986 Apr; 24(4):205-20. PubMed ID: 3009683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gelastic cataplexy in Niemann-Pick disease group C and related variants without generalized sphingomyelinase deficiency.
    Philippart M; Engel J; Zimmerman EG
    Ann Neurol; 1983 Oct; 14(4):492-3. PubMed ID: 6314876
    [No Abstract]   [Full Text] [Related]  

  • 11. New tools for the study of Niemann-Pick disease: analogues of natural substrate and Epstein-Barr virus-transformed lymphoid cell lines.
    Levade T; Salvayre R; Bes JC; Nezri M; Douste-Blazy L
    Pediatr Res; 1985 Jan; 19(1):153-7. PubMed ID: 2982124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A profound deficiency of (CH3-14C)choline sphingomyelin-cleaving enzyme in Niemann-Pick disease type B.
    Orii T; Nakamura F; Kudoh T; Tsuchihashi K; Nakao T
    Tohoku J Exp Med; 1975 Oct; 117(2):193-5. PubMed ID: 174246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of acid sphingomyelinase in Niemann-Pick mice].
    Sakiyama T; Kitagawa T
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):484-90. PubMed ID: 2024027
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibroblast phosphodiesterase deficiency in Niemann-Pick disease.
    Fensom AH; Benson PF; Babarik AW; Grant AR; Jacobs L
    Biochem Biophys Res Commun; 1977 Feb; 74(3):877-83. PubMed ID: 191016
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sphingomyelinase activity in a patient with Niemann-Pick disease].
    Sengers RC; Wevers RA; van Haelst UJ; Smeets HL
    Tijdschr Kindergeneeskd; 1989 Apr; 57(2):70-3. PubMed ID: 2545015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of acid sphingomyelinase in the mitochondria-lysosome fraction of brain from Niemann-Pick mice.
    Tsuda M; Owada M; Kitagawa T; Miyawaki S
    J Inherit Metab Dis; 1985; 8(3):147-8. PubMed ID: 3027450
    [No Abstract]   [Full Text] [Related]  

  • 17. [Type C Niemann-Pick disease in 2 siblings. Biochemical bases of its diagnosis].
    Pámpols T; Pineda M; Ferreter M; Fernández E
    An Esp Pediatr; 1986 Apr; 24(4):250-6. PubMed ID: 3014938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Niemann-Pick disease type B: prenatal diagnosis and enzymatic and chemical studies on fetal brain and liver.
    Wenger DA; Kudoh T; Sattler M; Palmieri M; Yudkoff M
    Am J Hum Genet; 1981 May; 33(3):337-44. PubMed ID: 6264784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological studies on lysosomal sphingomyelinase: identification of a 28 000-Da component deficient in urine from patients with Niemann-Pick disease types A and B.
    Schram AW; Dreissen M; Bastiaannet J; Donker-Koopman WE; Brouwer-Kelder EM; Weitz G; Barranger JA; Sandhoff K; Tager JM
    Biosci Rep; 1984 Dec; 4(12):1051-7. PubMed ID: 6099155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activators for sphingohydrolases and the nature of the sphingomyelinase deficiency in Niemann-Pick disease types A, B and C (author's transl)].
    Baraton G; Revol A
    Clin Chim Acta; 1977 May; 76(3):339-43. PubMed ID: 192496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.